Insider · CIK 0001089409

DEPTULA-HICKS DARLENE M

Reports to the SEC for 7 companies · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001089409

Forms 4 and 5

Insider transactions

38 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-09	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+84.6K sh	—	—	84,557
2026-06-09	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,756 sh	—	—	9,756
2023-03-08	F-star Therapeutics, Inc.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−25.5K sh	$7.12	−$182K	0
2023-03-08	F-star Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−59.8K sh	—	—	0
2023-03-08	F-star Therapeutics, Inc.U Disposition from Tender	See Remarks	UDisposition from Tender	−30.9K sh	$7.12	−$220K	25,539
2023-03-08	F-star Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−24.9K sh	—	—	0
2023-03-08	F-star Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−28.4K sh	—	—	0
2023-03-08	F-star Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−25.9K sh	—	—	0
2022-03-31	F-star Therapeutics, Inc.Stock Option (right to buy)A Award	See Remarks	AAward	+24.9K sh	—	—	24,902
2022-01-09	F-star Therapeutics, Inc.Stock Option (right to buy)A Award	See Remarks	AAward	+59.8K sh	—	—	59,823
2021-03-09	F-star Therapeutics, Inc.Stock Option (right to buy)A Award	See Remarks	AAward	+25.9K sh	—	—	54,320
2021-02-01	F-star Therapeutics, Inc.A Award	See Remarks	AAward	+30K sh	—	—	56,437
2020-11-20	F-star Therapeutics, Inc.Restricted Stock UnitsA Award	See Remarks	AAward	+26.4K sh	—	—	26,437
2020-11-20	F-star Therapeutics, Inc.Stock Option (right to buy)A Award	See Remarks	AAward	+28.4K sh	—	—	28,426
2020-11-20	F-star Therapeutics, Inc.A Award	See Remarks	AAward	+26.4K sh	—	—	26,437
2017-06-06	T2 Biosystems, Inc.P Purchase	SVP & Chief Financial Officer	PPurchase	+4,000 sh	$3.58	+$14.3K	4,000
2016-12-20	XBIOXenetic Biosciences, Inc. · Stock OptionA Award	Director	AAward	+10K sh	—	—	20,000
2016-12-20	XBIOXenetic Biosciences, Inc. · Stock OptionA Award	Director	AAward	+10K sh	—	—	61,416
2016-12-20	XBIOXenetic Biosciences, Inc. · Stock OptionA Award	Director	AAward	+10K sh	—	—	10,000
2016-12-20	XBIOXenetic Biosciences, Inc. · Stock OptionA Award	Director	AAward	+10K sh	—	—	30,000
2016-12-20	XBIOXenetic Biosciences, Inc. · Stock OptionA Award	Director	AAward	+10K sh	—	—	40,000
2016-12-20	XBIOXenetic Biosciences, Inc. · Stock OptionA Award	Director	AAward	+10K sh	—	—	51,416
2016-12-20	XBIOXenetic Biosciences, Inc. · Stock OptionA Award	Director	AAward	+10K sh	—	—	41,416
2016-12-20	XBIOXenetic Biosciences, Inc. · Stock OptionA Award	Director	AAward	+10K sh	—	—	31,416
2016-06-13	PVLAPALVELLA THERAPEUTICS, INC.P Purchase	SVP, Chief Financial Officer	PPurchase	+5,000 sh	$1.66	+$8,300	5,000
2016-05-01	T2 Biosystems, Inc.Stock Option (Right to Buy)A Award	SVP & Chief Financial Officer	AAward	+175K sh	—	—	175,000
2015-09-01	PVLAPALVELLA THERAPEUTICS, INC. · Common StockA Award	SVP, Chief Financial Officer	AAward	+450K sh	—	—	450,000
2011-03-29	ICAD INCEmployee Stock Option (right to buy)A Award	Exec VP of Finance, CFO	AAward	+100K sh	—	—	100,000
2011-03-03	ICAD INCF Tax Payment	Exec VP of Finance, CFO	FTax Payment	−5,108 sh	$1.24	−$6,333.92	125,055
2010-07-19	ICAD INCF Tax Payment	Exec VP of Finance, CFO	FTax Payment	−4,408 sh	$2.00	−$8,816	130,163
2010-06-01	ICAD INCF Tax Payment	Exec VP of Finance, CFO	FTax Payment	−6,613 sh	$1.43	−$9,456.59	134,571
2010-03-11	ICAD INCS Sale	Exec VP of Finance, CFO	SSale	−19.6K sh	$1.40	−$27.5K	141,184
2010-03-10	ICAD INCS Sale	Exec VP of Finance, CFO	SSale	−100 sh	$1.41	−$141	165,883
2010-03-10	ICAD INCS Sale	Exec VP of Finance, CFO	SSale	−5,070 sh	$1.40	−$7,098	160,813
2010-03-09	ICAD INCS Sale	Exec VP of Finance, CFO	SSale	−201 sh	$1.41	−$283.41	165,983
2010-03-01	ICAD INCA Award	Exec VP of Finance, CFO	AAward	+50K sh	—	—	166,184
2009-07-18	ICAD INCF Tax Payment	Exec VP of Finance, CFO	FTax Payment	−4,408 sh	$1.18	−$5,201.44	116,184
2008-06-25	ICAD INCA Award	Exec VP of Finance, CFO	AAward	+75K sh	—	—	125,000

Recent filings

Accepted (ET)
Jun 114
DEPTULA-HICKS DARLENE M0001193125-26-267587
SEC(opens sec.gov)
Mar 94
DEPTULA-HICKS DARLENE M0000899243-23-007665
SEC(opens sec.gov)
Apr 44
DEPTULA-HICKS DARLENE M0001209191-22-022308
SEC(opens sec.gov)
Jan 114
DEPTULA-HICKS DARLENE M0001209191-22-002920
SEC(opens sec.gov)
Aug 244/A
DEPTULA-HICKS DARLENE M0001209191-21-053227
SEC(opens sec.gov)
Mar 114
DEPTULA-HICKS DARLENE M0001209191-21-019769
SEC(opens sec.gov)
Feb 24
DEPTULA-HICKS DARLENE M0001209191-21-006720
SEC(opens sec.gov)
Nov 244
DEPTULA-HICKS DARLENE M0001209191-20-060353
SEC(opens sec.gov)
Jun 154/A
Xenetic Biosciences, Inc.0001662252-17-000119
SEC(opens sec.gov)
Jun 84
T2 Biosystems, Inc.0001104659-17-038149
SEC(opens sec.gov)

Companies

Address

C/O ALDEYRA THERAPEUTICS, INC. 131 HARTWELL AVENUE

LEXINGTON, MA, 02421